Understanding the Current Rating
The Strong Sell rating assigned to M K Proteins Ltd indicates a cautious stance for investors, signalling significant concerns across multiple evaluation parameters. This rating was revised on 14 August 2026, when the Mojo Score dropped from 31 to 28, reflecting a deterioration in the company’s overall outlook. MarketsMOJO’s rating system integrates various factors including quality, valuation, financial trends, and technical analysis to provide a comprehensive view of the stock’s investment potential.
Here’s How the Stock Looks Today
As of 15 September 2026, M K Proteins Ltd remains a microcap player in the edible oil sector, facing considerable headwinds. The company’s Mojo Grade is firmly in the Strong Sell category, with a current Mojo Score of 28. This score reflects a combination of average quality, attractive valuation, negative financial trends, and bearish technical indicators.
Quality Assessment
The quality grade for M K Proteins Ltd is rated as average. This suggests that while the company maintains some operational stability, it lacks the robust fundamentals that typically characterise higher-quality stocks. The long-term growth trajectory is particularly concerning, with operating profit shrinking at an annualised rate of -29.20% over the past five years. This sustained contraction highlights challenges in the company’s core business operations and raises questions about its ability to generate consistent earnings growth.
Valuation Perspective
Despite the negative outlook on quality and financial trends, the valuation grade is considered attractive. This implies that the stock is trading at a relatively low price compared to its earnings, book value, or cash flow metrics. For value-oriented investors, this could present a potential opportunity if the company’s fundamentals improve. However, attractive valuation alone does not offset the risks posed by deteriorating financial performance and weak technical signals.
Financial Trend Analysis
The financial grade is negative, reflecting the company’s recent performance and profitability challenges. The latest half-year results ending June 2026 show a significant decline in profitability metrics. Profit After Tax (PAT) stood at ₹2.52 crores, having contracted by 60.06%, while Profit Before Tax excluding other income (PBT less OI) fell by 60.72% to ₹1.85 crores. These sharp declines underscore the company’s struggles to maintain earnings momentum amid a challenging operating environment.
Additionally, the debtor turnover ratio for the half-year period is at a low 60.01 times, indicating potential inefficiencies in receivables management. This could impact cash flow and working capital, further straining the company’s financial health.
Technical Indicators
The technical grade is bearish, signalling downward momentum in the stock price. Recent price movements confirm this trend, with the stock showing a 3.83% decline over the past month and an 18.46% drop over the last three months. The six-month performance is similarly weak, with a 19.76% decrease. Year-to-date, the stock has lost 34.10%, and over the last year, it has delivered a steep negative return of 45.31%.
Such sustained underperformance relative to broader benchmarks like the BSE500, which the stock has underperformed in each of the last three annual periods, reinforces the bearish technical outlook. This trend suggests limited near-term upside and heightened risk for investors holding the stock.
Market Performance and Benchmark Comparison
Over the past year, M K Proteins Ltd has generated a negative return of 45.31%, significantly underperforming the BSE500 index. This consistent underperformance over multiple years highlights structural challenges within the company and the sector. Investors should be mindful that the stock’s microcap status may also contribute to higher volatility and liquidity risks.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
What the Strong Sell Rating Means for Investors
For investors, the Strong Sell rating on M K Proteins Ltd serves as a cautionary signal. It suggests that the stock currently carries elevated risks due to weak financial performance, deteriorating profitability, and negative price momentum. While the valuation appears attractive, this alone does not compensate for the underlying operational and market challenges.
Investors should carefully consider their risk tolerance and investment horizon before initiating or maintaining positions in this stock. The average quality and negative financial trends imply that a recovery may require significant operational improvements or favourable market developments. Meanwhile, the bearish technical indicators warn of continued downward pressure on the stock price in the near term.
Summary of Key Metrics as of 15 September 2026
- Mojo Score: 28.0 (Strong Sell)
- Quality Grade: Average
- Valuation Grade: Attractive
- Financial Grade: Negative
- Technical Grade: Bearish
- 1-Year Return: -45.31%
- Operating Profit Growth (5 years annualised): -29.20%
- PAT (Latest 6 months): ₹2.52 crores, down 60.06%
- PBT less Other Income (Latest quarter): ₹1.85 crores, down 60.72%
- Debtors Turnover Ratio (Half Year): 60.01 times
In conclusion, M K Proteins Ltd’s current Strong Sell rating reflects a comprehensive assessment of its operational challenges, financial deterioration, and negative market sentiment. Investors are advised to monitor the company closely for any signs of turnaround or improvement before considering exposure.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
